Tracleer
Links shared publicly online about this topic
Tracleer continues to fuel Actelion growth | InPharm
inpharm.com — “Tracleer continues to fuel Actelion growth | InPharm” View full resource at inpharm.com
Most Recently Shared on February 19, 2010 at 12:19 pm By:
Pharmafocus Health News and Pharma
Tracleer continues to fuel Actelion growth - Actelion has posted a 20% increase in revenue on the strength of its p... http://ow.ly/16CewF
Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets
news-medical.net — “Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia,” View full resource at news-medical.net
Most Recently Shared on March 26, 2010 at 5:40 pm By:
HIV/AIDS News: Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets: Invid... http://bit.ly/9Xv8bn
Actelion to hand over tracleer documents in U.S. | Reuters - Jack's posterous
pharmagossip.posterous.com — “Actelion to hand over tracleer documents in U.S. | Reuters - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on September 20, 2010 at 8:13 am By:
Jack Friday - PharmaGossip Health Blog
Actelion to hand over tracleer documents in U.S. | Reuters http://post.ly/ydaq
PharmaGossip: Actelion to hand over Tracleer documents in U.S. | Reuters
pharmagossip.blogspot.com — “PharmaGossip: Actelion to hand over Tracleer documents in U.S. | Reuters” View full resource at pharmagossip.blogspot.com
Most Recently Shared on September 20, 2010 at 8:13 am By:
Jack Friday - PharmaGossip Health Blog
PharmaGossip: Actelion to hand over tracleer documents in U.S. | Reuters: ZURICH, Sept 20 (Reuters) - Actelion Lt... http://bit.ly/c81qCW
Tracleer approved for mildly symptomatic WHO Functional Class II pulmonary arterial hypertension (PAH) - MPR
empr.com — “The FDA has approved Tracleer (bosentan tablets, from Actelion), a dual endothelin receptor antagonist, for the treatment of patients with mildly symptomatic World Health Organization (WHO) Functional Class II pulmonary arterial hypertension (PAH).” View full resource at empr.com
Most Recently Shared on August 11, 2009 at 3:42 pm By:
MPR News: Tracleer approved for mildly symptomatic WHO Functional Class II pulmonary arterial hypertens.. http://bit.ly/PcdfE
Actelion Pharmaceuticals Ltd (CH) - Actelion Pharmaceuticals US, Inc. has received subpoena relating to Tracleer - Drugs.com MedNews
drugs.com — “SOUTH SAN FRANCISCO, USA and ALLSCHWIL, SWITZERLAND - 20 September 2010 - Actelion Ltd. (SIX ATLN) announced today that its fully owned US subsidiary Actelion P” View full resource at drugs.com
Most Recently Shared on September 20, 2010 at 12:06 pm By:
Drugs and Devices OW OW Health
Actelion Pharmaceuticals Ltd (CH) - Actelion Pharmaceuticals US, Inc. has received subpoena relating to Tracl... http://bit.ly/cyFwot #drug
UPDATE 1-Actelion's key drug fails pulmonary fibrosis study | Reuters
reuters.com — “* Tracleer fails in idiopathic pulmonary fibrosis study * CEO says findings do not support regulatory application ZURICH, March 1 (Reuters) - Actelion said its drug Tracleer had failed” View full resource at reuters.com
Most Recently Shared on March 1, 2010 at 7:10 am By:
Ben Hirschler Health Communicator
A miss for #Actelion as Tracleer fails pulmonary fibrosis study http://www.reuters.com/article/idUSLDE62004L20100301
Actelion sale possible if new drug fails: report | Reuters
reuters.com — “ZURICH (Reuters) - Actelion could consider putting itself up for sale if key drug macitentan fails, an executive was quoted as saying on Sunday after the firm rebuffed the same demand from” View full resource at reuters.com
Most Recently Shared on June 13, 2011 at 11:23 am By:
John Carroll Health Communicator
Actelion exec says that if macitentan (Tracleer successor) fails, all options are on the table - including a sale. http://reut.rs/jE6Xs4
index
www1.actelion.com — “Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs. Find here the latest news & events.” View full resource at www1.actelion.com
Most Recently Shared on August 13, 2009 at 7:07 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
Bosentan (Tracleer®) now approved by FDA in addition to Ambrisentan (Letairis®) for WHO class II PAH patients. : http://tinyurl.com/mvta7q
Bosentan Helps Prevent Hand Ulcers (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A multinational clinical trial found that treatment with the endothelin receptor antagonist bosentan (Tracleer) showed some benefit in preventing new digital ulcers in patients with systemic sclerosis.” View full resource at qualitypointtech.net
Most Recently Shared on September 9, 2010 at 1:52 pm By:
Bosentan Helps Prevent Hand Ulcers (CME/CE): (MedPage Today) -- A multinational clinical trial found that treatmen... http://bit.ly/bHqlCV
A Victory For Gilead - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “When Gilead Sciences, the $8 billion (sales) maker of AIDS drugs, bought smaller drug developer Myogen for $2.5 billion in 2006, one rationale behind the deal was that Myogen's lead drug, Letairis, would have a key safety advantage over its main competitor, Tracleer, from Actelion: a lack of a so-called [...]” View full resource at blogs.forbes.com
Most Recently Shared on March 4, 2011 at 6:34 pm By:
Drugs and Devices OW OW Health
A Victory For Gilead: Good news for Gilead's drug for pulmonary arterial hypertension. http://bit.ly/hklNuI #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
-
News-Medical.Net
Stay up to date with the latest HIV/AIDS news and research via News-Medical.Net
-
Jack Friday - PharmaGossip
A Big Pharma Insider. Any post may be a joke!
Advertisement
